UBI Share Price

Open 0.46 Change Price %
High 0.47 1 Day -0.01 -2.13
Low 0.46 1 Week 0.03 6.98
Close 0.46 1 Month 0.08 21.05
Volume 106658 1 Year 0.19 70.37
52 Week High 0.48
52 Week Low 0.24
UBI Important Levels
Resistance 2 0.47
Resistance 1 0.47
Pivot 0.46
Support 1 0.45
Support 2 0.45
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
DUE 3.01 0.00%
DUE 3.01 0.00%
DJS 3.99 0.00%
DJS 3.99 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
BNV 0.03 50.00%
PMQ 0.03 50.00%
ARV 0.10 42.86%
EXG 0.04 33.33%
EXG 0.04 33.33%
BYR 0.05 25.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
COM 0.01 -50.00%
COM 0.01 -50.00%
COM 0.01 -50.00%
COM 0.01 -50.00%
More..

Universal Biosensors Inc (ASX: UBI)

UBI Technical Analysis 5
As on 24th Apr 2017 UBI Share Price closed @ 0.46 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.32 & Strong Buy for SHORT-TERM with Stoploss of 0.38 we also expect STOCK to react on Following IMPORTANT LEVELS.
UBI Target for April
1st Target up-side 0.45
2nd Target up-side 0.47
3rd Target up-side 0.5
1st Target down-side 0.37
2nd Target down-side 0.35
3rd Target down-side 0.32
UBI Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.universalbiosensors.com
UBI Address
UBI
1 Corporate Avenue
Rowville, VIC 3178
Australia
Phone: 61 3 9213 9000
Fax: 61 3 9213 9099
Interactive Technical Analysis Chart Universal Biosensors Inc ( UBI ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Universal Biosensors Inc
UBI Business Profile
Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a medical diagnostics company in Australia. It focuses on the research, development, and manufacture of a range of in vitro diagnostic test devices for consumer and professional point-of-care use. The company uses electrochemical cell technology platform to develop tests for various markets. It is developing a range of products for the point-of-care coagulation market through a collaboration agreement with Siemens Healthcare Diagnostics, Inc.; prothrombin time international normalized ratio test targeted at the patient self-test market; and other electrochemical-cell based tests, such as tests based on enzymatic, immunoassay, and molecular diagnostic methods. In addition, it provides contract research and development services, and other services. The company has research and development agreement with LifeScan, Inc. Universal Biosensors, Inc. was founded in 2001 and is based in Rowville, Australia.